2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha has been researched along with dazoxiben in 1 studies
Studies (2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha) | Trials (2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha) | Recent Studies (post-2010) (2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha) | Studies (dazoxiben) | Trials (dazoxiben) | Recent Studies (post-2010) (dazoxiben) |
---|---|---|---|---|---|
6 | 1 | 0 | 292 | 27 | 10 |
Protein | Taxonomy | 2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha (IC50) | dazoxiben (IC50) |
---|---|---|---|
Aromatase | Homo sapiens (human) | 1.1 | |
Thromboxane-A synthase | Homo sapiens (human) | 0.5985 | |
Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.9512 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brash, AR; FitzGerald, GA; Oates, JA; Pedersen, AK | 1 |
1 trial(s) available for 2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha and dazoxiben
Article | Year |
---|---|
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
Topics: Adult; Bleeding Time; Depression, Chemical; Dose-Response Relationship, Drug; Epoprostenol; Humans; Imidazoles; Male; Oxidoreductases; Platelet Aggregation; Prostaglandins F, Synthetic; Thromboxane B2; Thromboxane-A Synthase | 1983 |